Sigma-1 receptor ligands inhibit catecholamine secretion from adrenal chromaffin cells due to block of nicotinic acetylcholine receptors.
Sigma-1 receptor ligands inhibit catecholamine secretion from adrenal chromaffin cells due to block of nicotinic acetylcholine receptors.
复制标题
DOI:
10.1111/jnc.14149
复制
发表时间:
2017-10
影响因子:
4.7
通讯作者:
Currie KPM
中科院分区:
文献类型:
--
作者:
Brindley RL;Bauer MB;Hartley ND;Horning KJ;Currie KPM
Adrenal chromaffin cells (ACCs) are the neuroendocrine arm of the sympathetic nervous system and key mediators of the physiological stress response. Acetylcholine (ACh) released from preganglionic splanchnic nerves activates nicotinic acetylcholine receptors (nAChRs) on chromaffin cells causing membrane depolarization, opening voltage-gated Ca2+ channels (VGCC), and exocytosis of catecholamines and neuropeptides. The serotonin transporter (SERT) is expressed in ACCs and interacts with 5-HT1A receptors to control secretion. In addition to blocking SERT, some selective serotonin reuptake inhibitors (SSRIs) are also agonists at sigma-1 receptors which function as intracellular chaperone proteins and can translocate to the plasma membrane to modulate ion channels. Therefore, we investigated whether SSRIs and other sigma-1 receptor ligands can modulate stimulus-secretion coupling in ACCs. Escitalopram and fluvoxamine (100nM – 1μM) reversibly inhibited nAChR currents. The sigma-1 receptor antagonists NE-100 and BD-1047 also blocked nAChR currents (≈50% block at 100nM) as did PRE-084, a sigma-1 receptor agonist. Block of nAChR currents by fluvoxamine and NE-100 was not additive suggesting a common site of action. VGCC currents were unaffected by the drugs. Neither the increase in cytosolic [Ca2+] or the resulting catecholamine secretion evoked by direct membrane depolarization to bypass nAChRs were altered by fluvoxamine or NE-100. However, both Ca2+ entry and catecholamine secretion evoked by the cholinergic agonist carbachol were significantly reduced by fluvoxamine or NE-100. Together, our data suggest that sigma-1 receptors do not acutely regulate catecholamine secretion. Rather, SSRIs and other sigma-1 receptor ligands inhibit secretion evoked by cholinergic stimulation due to direct block of Ca2+entry via nAChRs. Sigma-1 receptors are intracellular chaperone proteins that can translocate to the plasma membrane to modulate various ion channels and cellular functions. We investigated the impact of several sigma-1 receptor ligands including fluvoxamine (a selective serotonin reuptake inhibitor) on catecholamine secretion from adrenal chromaffin cells. Our data suggest that sigma-1 receptors do not acutely regulate catecholamine secretion. Rather, sigma-1 receptor ligands inhibited secretion evoked by cholinergic stimulation due to direct block of Ca2+entry via nicotinic acetylcholine receptors.
登录
查看更多内容
影响因子:
15.9
作者:
Kourrich S;Su TP;Fujimoto M;Bonci A
通讯作者:
Bonci A
影响因子:
5
作者:
Brindley RL;Bauer MB;Blakely RD;Currie KPM
通讯作者:
Currie KPM
影响因子:
2.9
作者:
Arias, Hugo R.;Feuerbach, Dominik;Jozwiak, Krzysztof
通讯作者:
Jozwiak, Krzysztof
影响因子:
4.7
作者:
Fryer, JD;Lukas, RJ
通讯作者:
Lukas, RJ
影响因子:
15.9
作者:
Mahata, SK;OConnor, DT;Parmer, RJ
通讯作者:
Parmer, RJ